References
- Dobson L, Sheldon CD, Hattersley AT. Understanding cystic-fibrosis-related diabetes: Best thought of as insulin deficiency?. J R Soc Med 2004; 97(Suppl. 22)26–35
- Mackie ADR, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med 2003; 20: 425–436
- Robert JJ, Grasset E, De Montalembert M, Chevenne D, Deschamps I, Boitard C, Lenoir G. Reserche de facteurs d'intolerance au glucose dans la mucoviscidose. Arch Fr Pediatr 1992; 49: 17–22
- Lanng S, Hansen A, Thorsteinnson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: Five years prospective study. Br Med J 1995; 311: 655–659
- Lanng S, Thorsteinnson B, Roder ME, Orskov C, Holst JJ, Nerup J, Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagons in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol 1993; 128: 207–214
- Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715–723
- Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994; 43: 163–167
- Taylor CJ, Baxter PS, Hardcastle J, Hardcastle PT, Goldhill J. Glucose intolerance in cystic fibrosis. Arch Dis Child 1989; 64: 759
- De Luca F, Arrigo T, Conti Nibali S, Sferlazzas C, Gigante A, Di Cesare E, Cucinotta D. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 1991; 23: 495–498
- Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221–229
- Schloot NC, Meierhoff G, Karlsson Faresjő M, Ott P, Putnam A, Lehmann P, Gottlieb P, Roep BO, Peakman M, Tree T. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003; 21: 365–376
- Kotani R, Nagata M, Moriyama H, Nakayama M, Yamada K, Chowdhury SA, Chakrabarty S, Jin Z, Yasuda H, Yokono K. Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT Assays. Diabetes Care 2002; 25: 1390–1397
- Lanng S, Thorsteinsson B, Roder ME, Orskov C, Holst JJ, Nerup J, Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagons in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance. Acta Endocrinol 1993; 128: 207–214
- Soejima K, Landing BH. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus. Morphometric and immunocytologic studies. Pediatr Pathol 1986; 6: 25–46
- Stutchfield PR, O'Halloran SM, Smith CS, Woodrow JC, Bottazzo GF, Heaf D. HLA type, islet cell antibodies and glucose intolerance in cystic fibrosis. Arch Dis Child 1988; 63: 1234–1239
- Lanng S, Thorsteinsson B, Pociot F, Marshall MO, Madsen HO, Schwartz M, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: Genetic and immunological markers. Acta Pediatr 1993; 82: 150–154
- Nousia-Arvanitakis S, Galli-Tsinopoulou A, Dracoulacos D, Karamouzis M, Demitriadou A. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocrinol Metab 2000; 13(3)319–324
- Perez-Payarols J, Julia Benique MR, Matamoros Flori N, Roman Pinana JM. An increase in gamma-delta T-lymphocytes in the peripheral blood of cystic fibrosis patients. An Esp Pediatr 1996; 44(3)239–241
- Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366(6450)69–72